Cochrane · systematic review · CD011574

Interventions for preventing falls in Parkinson's disease

Allen, NE, Canning, CG, Almeida, LRS, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

Movement DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
24
current version
GRADE rated
18
No studies
6
Included studies
NR
No studies 6 · 25%Ungraded 0 · 0%Very low 12 · 50%Low 4 · 16.7%Moderate 2 · 8.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Summary of findings for exercise compared to control

Population: People with Parkinson's disease
6 questions
OutcomeEffectEvidenceStatus / GRADE
Rate of Falls (falls per person‐year)
Summary of findings for exercise vs control
Rate ratio 0.74 [0.63, 0.87]12 studies · 1456 participantsModerate
Downgraded: risk of bias, indirectness
Number of people who experienced one or more falls
Summary of findings for exercise vs control
Risk ratio 0.9 [0.8, 1]9 studies · 932 participantsModerate
Downgraded: risk of bias, indirectness
Number of people sustaining one or more fall‐related fractures
Summary of findings for exercise vs control
Risk ratio 0.57 [0.28, 1.17]5 studies · 989 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Quality of life immediately after the intervention
Summary of findings for exercise vs control
no estimate extracted5 studies · 951 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Adverse events
Summary of findings for exercise vs control
no estimate extracted8 studies · 1242 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Economic outcomes
Summary of findings for exercise vs control
no estimate extracted4 studies · 923 participantsVery low
Downgraded: risk of bias, imprecision, indirectness

Summary of findings for cholinesterase inhibitors compared to placebo

Population: People with Parkinson's disease
6 questions
OutcomeEffectEvidenceStatus / GRADE
Rate of falls (falls per person‐year)
Summary of findings for cholinesterase inhibitors vs placebo
Rate ratio 0.5 [0.44, 0.58]3 studies · 229 participantsLow
Downgraded: risk of bias, imprecision
Number of people who experienced one or more falls
Summary of findings for cholinesterase inhibitors vs placebo
no estimate extracted3 studies · 230 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Number of people sustaining one or more fall‐related fractures
Summary of findings for cholinesterase inhibitors vs placebo
no estimate extracted1 study · 23 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Quality of Life immediately after the intervention (EQ5D Thermometer, scale 0 to 100; and EQ5D Index Score, scale 0‐1, high score is better quality of life)
Summary of findings for cholinesterase inhibitors vs placebo
no estimate extracted1 study · 121 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Rate of adverse events excluding falls (per person year)
Summary of findings for cholinesterase inhibitors vs placebo
Rate ratio 1.6 [1.28, 2.01]2 studies · 175 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Economic outcomes
Summary of findings for cholinesterase inhibitors vs placebo
no estimate extractedNRNo studies

Summary of findings for education compared to control

Population: People with Parkinson's disease
6 questions
OutcomeEffectEvidenceStatus / GRADE
Rate of falls (falls per person‐year)
Summary of findings for education vs control
no estimate extractedNRNo studies
Number of people who experienced one or more falls
Summary of findings for education vs control
Risk ratio 10.89 [1.26, 94.03]1 study · 53 participantsVery low
Downgraded: risk of bias, imprecision
Number of people sustaining one or more fall‐related fractures
Summary of findings for education vs control
no estimate extractedNRNo studies
Quality of life
Summary of findings for education vs control
no estimate extractedNRNo studies
Adverse events
Summary of findings for education vs control
no estimate extractedNRNo studies
Economic outcomes
Summary of findings for education vs control
no estimate extractedNRNo studies

Summary of findings for exercise plus education compared to control

Population: People with Parkinson's disease
6 questions
OutcomeEffectEvidenceStatus / GRADE
Rate of Falls (falls per person‐year)
Summary of findings for exercise plus education vs control
Rate ratio 0.46 [0.12, 1.85]2 studies · 320 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Number of people who experienced one or more falls
Summary of findings for exercise plus education vs control
Risk Ratio 0.89 [0.75, 1.07]3 studies · 352 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Number of people sustaining one or more fall‐related fractures
Summary of findings for exercise plus education vs control
Risk ratio 1.45 [0.4, 5.32]2 studies · 320 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Quality of life immediately after the intervention
Summary of findings for exercise plus education vs control
no estimate extracted2 studies · 305 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Adverse events
Summary of findings for exercise plus education vs control
no estimate extracted2 studies · 343 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Economic Outcomes
Summary of findings for exercise plus education vs control
no estimate extracted1 study · 133 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness